Skip to main content
. 2016 May 31;82(2):340–351. doi: 10.1111/bcp.12961

Figure 1.

Figure 1

The different modes of action for therapeutic oligonucleotides. A) Activation or inhibition of the target protein to induce or inhibit immune activation. B) Exon skipping to induce alternative splicing. C) Inhibition of mRNA with antisense ON inhibits production of the protein